Scenarios that move ACAD

ACADIA Pharmaceuticals Inc. - Common Stock

Scenarios that move ACAD: 2 analyses, 2 positive, 0 negative.

1. 2026-09-18 · Xenon files epilepsy NDA as depression study setback weighs — ▲ · impact +7 · confidence low · horizon quarters
2. 2026-09-15 · Definium reports second Phase III success in anxiety program — ▲ · impact +35 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing